Abstract

Autograft is still playing the role of gold standard in critical sized and non-union bone defects. Hence, adequate bone substitutes for remodelling of native bone tissue are a goal to achieve: biopolymers, bioglasses and bioceramics are often considered to satisfy, at least in part, requirements for bone regeneration, but composite solutions are believed to represent the future, bearing cues from both mineral components and polymeric ones.